Westpac Banking Corp’s Alnylam Pharmaceuticals ALNY Stock Holding History

Westpac Banking Corp’s Portfolio ALNY Stock Details ALNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$442K	Sell	1,355 -3,718	-73%	-$1.21M	0.03%	265
2025 Q1	$1.37M	Sell	5,073 -5,487	-52%	-$1.48M	0.1%	187
2024 Q4	$2.48M	Buy	10,560 +4,819	+84%	+$1.13M	0.16%	141
2024 Q3	$1.58M	Buy	5,741 +4,274	+291%	+$1.18M	0.11%	186
2024 Q2	$356K	Hold	1,467	–	–	0.03%	276
2024 Q1	$219K	Sell	1,467 -45	-3%	-$6.73K	0.02%	335
2023 Q4	$289K	Buy	1,512 +566	+60%	+$108K	0.02%	304
2023 Q3	$168K	Hold	946	–	–	0.01%	402
2023 Q2	$180K	Sell	946 -10,316	-92%	-$1.96M	0.01%	370
2023 Q1	$2.26M	Hold	11,262	–	–	0.03%	505
2022 Q4	$2.68M	Buy	11,262 +861	+8%	+$205K	0.04%	449
2022 Q3	$2.08M	Buy	10,401 +1,877	+22%	+$376K	0.03%	500
2022 Q2	$1.24M	Hold	8,524	–	–	0.02%	626
2022 Q1	$1.39M	Hold	8,524	–	–	0.02%	643
2021 Q4	$1.45M	Sell	8,524 -2,445	-22%	-$415K	0.02%	637
2021 Q3	$2.07M	Hold	10,969	–	–	0.02%	580
2021 Q2	$1.86M	Hold	10,969	–	–	0.02%	622
2021 Q1	$1.55M	Hold	10,969	–	–	0.02%	606
2020 Q4	$1.43M	Hold	10,969	–	–	0.02%	640
2020 Q3	$1.6M	Hold	10,969	–	–	0.02%	581
2020 Q2	$1.62M	Hold	10,969	–	–	0.02%	549
2020 Q1	$1.19M	Hold	10,969	–	–	0.02%	553
2019 Q4	$1.26M	Buy	10,969 +5,280	+93%	+$608K	0.02%	639
2019 Q3	$458K	Hold	5,689	–	–	0.01%	801
2019 Q2	$413K	Hold	5,689	–	–	0.01%	678
2019 Q1	$532K	Hold	5,689	–	–	0.01%	640
2018 Q4	$415K	Hold	5,689	–	–	0.01%	738
2018 Q3	$498K	Hold	5,689	–	–	0.01%	654
2018 Q2	$560K	Hold	5,689	–	–	0.01%	613
2018 Q1	$678K	Hold	5,689	–	–	0.01%	570
2017 Q4	$723K	Buy	+5,689	New	+$723K	0.02%	536
2016 Q4	–	Sell	-4,274	Closed	-$290K	–	817
2016 Q3	$290K	Hold	4,274	–	–	﹤0.01%	762
2016 Q2	$237K	Buy	4,274 +1,057	+33%	+$58.7K	﹤0.01%	824
2016 Q1	$202K	Hold	3,217	–	–	﹤0.01%	802
2015 Q4	$303K	Sell	3,217 -12,164	-79%	-$1.15M	﹤0.01%	770
2015 Q3	$1.24M	Buy	15,381 +14,882	+2,982%	+$1.2M	0.01%	499
2015 Q2	$59.8K	Buy	+499	New	+$59.8K	﹤0.01%	780